Gavin Li is an experienced professional in clinical development and epidemiology, currently serving as the Sr. Manager of the Clinical Development Department at Amphastar Pharmaceuticals, Inc. since July 2015. Prior to this role, Gavin worked as a Clinical Monitoring and Safety Associate at Everest Clinical Research Services Inc., where responsibilities included clinical and safety monitoring, SAE reports review, and medical coding of adverse events. Earlier experience includes serving as an Epidemiologist at Queen's University, overseeing studies on the effectiveness and safety of oncology pharmaceuticals, as well as assisting in the design of clinical trials. Gavin began a medical career as an Attending Physician at Peking Union Medical College Hospital. Academic qualifications include a Master of Science in Epidemiology from Queen's University and a Doctor of Medicine from Tianjin Medical University.